Transmission blocking malaria vaccines

Vaccine

Volumn 19, Issue 17-19, 2001, Pages 2309-2314

  Carter, Richard ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Malaria; Transmission; Vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIMALARIAL AGENT; ANTISERUM; MALARIA VACCINE; MEMBRANE PROTEIN; PROTEIN PFS25; PROTEIN PVS25; UNCLASSIFIED DRUG;

CLINICAL TRIAL; COMMUNITY; CONFERENCE PAPER; DISEASE TRANSMISSION; HUMAN; IMMUNITY; IMMUNIZATION; MALARIA; MOSQUITO; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; SKIN MANIFESTATION;

ANIMALS; ANTIGENS, PROTOZOAN; CULICIDAE; HUMANS; MALARIA; MALARIA VACCINES; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; VACCINATION;

EID: 0035925588     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00521-1     Document Type: Conference Paper

References (24)

1. Predicted disulphide bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12
2. Properties of epitopes of Pfs48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum
3. Immunity to sexual stages of malaria parasites
4. Malaria Control and the Spatial Targeting of Malaria Interventions
5. Target antigens in malaria transmission blocking immunity
6. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines
7. Conserved and variant epitopes of target antigens of transmission-blocking antibodies among isolates of Plasmodium falciparum from Malaysia
8. A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission blocking antibodies
9. Transmission-blocking immunity against malaria and other vector-borne diseases
10. Transmission-blocking vaccines: Uses and current status of development
11. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains
12. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose
13. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes
14. Cloning and expression of the gene for the transmission blocking target antigen PFS 48/45 of Plasmodium falciparum
15. The neglected burden of Plasmodium vivax malaria
16. Transmission-blocking antibodies against multiple target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing
17. Target antigens of transmission blocking immunity on gametes of Plasmodium falciparum
18. Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease
19. Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230
20. Comparison of Plasmodium yoelii ookinete surface antigens with human and avian malaria parasites homologues reveals two highly conserved regions
21. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates
22. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito
23. Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs 230